Suchergebnisse - "Spiekermann, Karsten"

PubPharm (9)

1

Compatibility of RUNX1/ETO fusion protein modules driving CD34+ human progenitor cell expansion

enthalten in: Oncogene | 2019

von Chen-Wichmann, L. | Shvartsman, M. | Preiss, C. | +10

2

Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis

enthalten in: Haematologica | 2017

von Herold, T. | Schneider, S. | Metzeler, K. | +21

3

MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML

enthalten in: Cell reports | 2016

von Vegi, N. | Klappacher, J. | Oswald, F. | +16

4

ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation

enthalten in: Nature communications | 2016

von Hartmann, L. | Dutta, S. | Opatz, S. | +31

5

Exome sequencing identifies recurring FLT3 N676K mutations in core-binding factor leukemia

enthalten in: Blood | 2013

von Opatz, S. | Polzer, H. | Herold, T. | +20

6

KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival

enthalten in: Blood | 2006

von Schnittger, S. | Kohl, T. | Haferlach, T. | +4

7

The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice

enthalten in: The Journal of clinical investigation | 2005

von Schessl, C. | Rawat, V. | Cusan, M. | +12

8

The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells

enthalten in: Experimental hematology | 2002

von Spiekermann, K. | Faber, F. | Voswinckel, R. | +1

9

Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells

enthalten in: Experimental hematology | 2002

von Spiekermann, K. | Pau, M. | Schwab, R. | +3

1
[1]